Biocatalysis plant obtained ISO9001, ISO2000, Kosher and other related certifications.
In 2013
Carry out preclinical experiments and new drug research and development services, cooperate with laboratories to obtain GLP certification.
In 2015
Shanghai sales platform was established, using international talents to serve multinational customers.
In 2011
Jiangxi Qianshan plant started construction, and CRO and CDMO services were gradually launched.
In 2008
Zhangjiang Pharmaceutical Valley Chemical R&D Laboratory was established to help international pharmaceutical groups provide customized synthesis and chemistry services.
In 2012
Biocatalysis Research Center was established. In the same year, a similar GMP biocatalysis plant was built to optimize product processes and reduce three wastes, conduct technological innovation.
In 2016
Cooperate with Shandong GMP and FDA factories, which have passed audits in Japan, South Korea, the European Union and other countries to meet the diversified high-end needs of customers.
In 2010
Scale up labs and production, and build compound libraries.
In 2009
Carry out process research and development services and scale up around commercial production.
In 2019
Cooperate with the pharmaceutical preparations factory which cover an area of 4,000 square meters, including tablets, capsules, ointments and other research services.
In 2020
We provide drug development services for ADCs (antibody-drug conjugates).
In 2022
Carry out clinical and commercial services for peptide drugs, cells and their gene therapies.
In 2018
Cooperate with the drug consistency evaluation platform and carry out CMC services for preclinical and clinical research of new drugs.
In 2017
Cooperate with the GMP factory in Huainan to carry out CXMO services for pharmaceutical intermediates and APIs.
